Drug Trial Radar · NCT06951802
Endometriosis and Pain Treatment by Intraoperative Administration of Low-dose Ketamine
Last checked: Nov 20, 2026Latest source record: Apr 30, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
118
Planned (sponsor's estimate)
Start
Dec 3, 2024
Primary completion
Jun 30, 2025
Study completion Dec 31, 2026
Sponsor
- Lead sponsor
- Insel Gruppe AG, University Hospital BernAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Apr 30, 2025
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
RCT comparing intraoperative administration of low-dose ketamine during laparoscopic endometriosis operation and the postoperative pain outcome
Conditions
- Endometriosis
Interventions
KetamineDrug
Low-dose administration of ketamine during laparoscopic surgery
PropofolDrug
Control group
Primary outcomes
What the sponsor says the trial is designed to measure.
- Total opioids prescribed and consumed during hospitalization for endometriosis.Time frame: During hospitalisation, expected to be on average 2-5 days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Inselspital Bern
Bern, Switzerland · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.